Patent details
EP3733175 Title: CANCER THERAPEUTIC
Basic Information
- Publication number:
- EP3733175
- PCT Application Number:
- JP2018028887
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP188947667
- PCT Publication Number:
- WO2019130637
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CANCER THERAPEUTIC
- French Title of Invention:
- TRAITEMENT DU CANCER
- German Title of Invention:
- THERAPEUTIKA GEGEN KREBS
- SPC Number:
Dates
- Filing date:
- 01/08/2018
- Grant date:
- 04/10/2023
- EP Publication Date:
- 04/11/2020
- PCT Publication Date:
- 04/07/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/10/2023
- EP B1 Publication Date:
- 04/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 01/08/2024
- Expiration date:
- 01/08/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/09/2023
- Name:
- J-Pharma Co., Ltd.
- Address:
- 75-1 Onocho Tsurumi-ku Yokohama-shi, Kanagawa 230-0046, Japan (JP)
Inventor
1
- Name:
- ENDOU Hitoshi
- Address:
- Japan (JP)
2
- Name:
- FURUSE Junji
- Address:
- Japan (JP)
3
- Name:
- WEMPE Michael F.
- Address:
- United States (US)
4
- Name:
- OKAYASU Isao
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2017253385
- Priority Date:
- 28/12/2017
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- A61K 31/423; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|